IMPEDE VTE score for multiple myeloma

Risk stratification score for venous thromboembolism in multiple myeloma.

Choose the applicable option for each risk factor.

Scoring items

Receiving immunomodulatory therapy

BMI ≥25 kg/m^2

Pelvic, hip, or femur fracture

Erythropoiesis-stimulating agent use

Doxorubicin use

Dexamethasone dose

Race

Prior VTE before myeloma diagnosis

Tunneled line or central venous catheter

Therapeutic thromboprophylaxis

Prophylactic thromboprophylaxis

Please complete all required fields first.

Important Notice

This resource is intended for educational purposes only and is intended for US healthcare professionals. Healthcare professionals should use independent medical judgment. All decisions regarding patient care must be handled by a healthcare professional and be made based on the unique needs of each patient.